Kiana Mehring Discusses the Future of Value-Based Oncology Care

Patient-reported outcomes are crucial to the future landscape of value-based oncology care and research models, says Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute (FCS).

Transcript

How do you see the future of value-based oncology care evolving, both within FCS and in the broader health care landscape?

One of the exciting things that value-based care has been moving toward in recent years is a patient-centric approach. The landscape is shifting to tailor treatments to individual patient needs, their preferences, outcomes, etc. Personalized medicine is certainly on the rise and patient engagement continues to be important.

I think another thing we're going to see in the coming years is more and more patient-reported outcomes. As we implement it into care models, that is really going to ensure that we're making our decisions, not without the patient included, but including the patient in the center of those decisions with the oncologist.

I also believe there's going to be a continued emphasis on early detection and preventative strategies that are going to reduce the need for those costly, late-stage treatments.